Subsequent primary malignancies among multiple myeloma patients treated with or without lenalidomide. - Rollison DE; Komrokji R; Lee JH; Hampras S; Fulp W; Fisher K; Baz R; Nishihori T; Xu Q; Olesnyckyj M; Kenvin L; Knight R; et al. (Leukemia & lymphoma, 2017)